Latest news
Loading news…
Epsilen Bio
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Milan, Lombardia, Italy Founded 2019 11-50 employees For Profit
Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases.
Epsilen Bio was acquired by Chroma Medicine in 2021.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- c12
- IT spend
- $345K
Company Info
- Founded
- 2019
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 1
- HQ
- Milan, Lombardia, Italy
- Region
- European Union (EU), Europe, Middle East, and Africa (EMEA)
- Exit date
- Nov 17, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 0
- Trend (30d)
- -0.9
- Trend (90d)
- -0.4
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Epsilen Bio
Loading news…
FAQs about Epsilen Bio
People who checked this page also checked these
Browse the full Acquirezy directory.